Polo-like kinase
Polo-like Kinase[edit | edit source]
Polo-like kinase (PLK) is a family of serine/threonine protein kinases that play crucial roles in cell cycle regulation and various cellular processes. They are named after their homology to the Drosophila melanogaster protein called Polo, which is involved in regulating cell division in flies. In humans, there are four known members of the PLK family: PLK1, PLK2, PLK3, and PLK4.
Discovery and Structure[edit | edit source]
The first member of the PLK family, PLK1, was discovered in the late 1990s and has since been extensively studied. PLK1 is composed of multiple functional domains, including a kinase domain responsible for phosphorylation, a polo-box domain involved in substrate recognition, and a C-terminal domain that regulates protein-protein interactions.
Functions[edit | edit source]
PLKs are primarily known for their roles in cell cycle regulation, particularly in mitosis. They are involved in various processes such as centrosome maturation, spindle assembly, chromosome segregation, and cytokinesis. PLKs also play important roles in DNA damage response, DNA replication, and cell survival.
Regulation[edit | edit source]
The activity of PLKs is tightly regulated to ensure proper cell cycle progression. They are subject to multiple levels of regulation, including phosphorylation, protein-protein interactions, and subcellular localization. PLKs are activated by phosphorylation of specific residues within their activation loops, and their activity is further modulated by interactions with other proteins and localization to specific cellular structures.
Clinical Significance[edit | edit source]
Due to their critical roles in cell cycle regulation, PLKs have emerged as potential targets for cancer therapy. Overexpression of PLK1 has been observed in various types of cancer, and its inhibition has shown promising results in preclinical and clinical studies. Several PLK inhibitors are currently being developed and tested as anticancer drugs.
References[edit | edit source]
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
